Trial NCT03502681

View at ClinicalTrials.gov 
Org. Study IDs: BTCRC-GU16-051

Last trial update was posted on 2022-07-01

MeSH Interventions

Avelumab

MeSH Conditions


Other Conditions

Metastatic Urothelial Cell Cancer

Stopping Reasons

Funder Decision

Limitations And Caveats

Due to the early termination of the study, no primary or secondary endpoints were analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID